Physiologic and biochemical basis for the treatment of gout and hyperuricemia.
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001168:Arthritis / Q000209:etiology; D002908:Chronic Disease; D003078:Colchicine / Q000627:therapeutic use; D005919:Glomerular Filtration Rate; D006073:Gout / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism / Q000517:prevention & control; D010653:Phenylbutazone / Q000627:therapeutic use; D011687:Purines / Q000378:metabolism; D014503:Urate Oxidase / Q000378:metabolism; D014527:Uric Acid / Q000096:biosynthesis / Q000097:blood* / Q000378:metabolism; D014528:Uricosuric Agents / Q000627:therapeutic use; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D000305:Adrenal Cortex Hormones; D011687:Purines; D014528:Uricosuric Agents; D014527:Uric Acid; D014969:Xanthine Oxidase; D014503:Urate Oxidase; D010653:Phenylbutazone; D003078:Colchicine